<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>444</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15634913</PubmedId>
            <Abstract>Multiple sclerosis (MS) is an autoimmune CNS demyelinating disease in which infection may be an important initiating factor. Pathogen-induced cross-activation of autoimmune T cells may occur by molecular mimicry. Infection with wild-type Theiler's murine encephalomyelitis virus induces a late-onset, progressive T cell-mediated demyelinating disease, similar to MS. To determine the potential of virus-induced autoimmunity by molecular mimicry, a nonpathogenic neurotropic Theiler's murine encephalomyelitis virus variant was engineered to encode a mimic peptide from protease IV of Haemophilus influenzae (HI), sharing 6 of 13 aa with the dominant encephalitogenic proteolipid protein (PLP) epitope PLP(139-151). Infection of SJL mice with the HI mimic-expressing virus induced a rapid-onset, nonprogressive paralytic disease characterized by potent activation of self-reactive PLP(139-151)-specific CD4(+) Th1 responses. In contrast, mice immunized with the HI mimic-peptide in CFA did not develop disease, associated with the failure to induce activation of PLP(139-151)-specific CD4(+) Th1 cells. However, preinfection with the mimic-expressing virus before mimic-peptide immunization led to severe disease. Therefore, infection with a mimic-expressing virus directly initiates organ-specific T cell-mediated autoimmunity, suggesting that pathogen-delivered innate immune signals may play a crucial role in triggering differentiation of pathogenic self-reactive responses. These results have important implications for explaining the pathogenesis of MS and other autoimmune diseases.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>907-17</ArticlePages>
            <ArticleTitle>Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Croxford</LastName>
                    <ForeName>J Ludovic</ForeName>
                </Author>
                <Author>
                    <LastName>Anger</LastName>
                    <ForeName>Holly A</ForeName>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>Stephen D</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Microbiology-Immunology, and Interdepartmental Immunobiology Center, Northwestern University Medical School, Chicago, IL 60611, USA.</Affiliations>
            <ArticleChemicalList>Autoantigens;Epitopes, T-Lymphocyte;Myelin Proteolipid Protein;Peptide Fragments;myelin proteolipid protein (139-151)</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Autoantigens(immunology); Brain Stem(immunology; pathology); Cell Movement(immunology); Cerebellum(immunology; pathology); Dose-Response Relationship, Immunologic; Encephalomyelitis, Autoimmune, Experimental(immunology; microbiology; pathology; virology); Epitopes, T-Lymphocyte(administration &amp; dosage; immunology); Female; Genetic Vectors; Haemophilus influenzae(genetics; immunology); Lymphocyte Activation(immunology); Mice; Molecular Mimicry(genetics; immunology); Molecular Sequence Data; Myelin Proteolipid Protein(administration &amp; dosage; immunology); Peptide Fragments(administration &amp; dosage; immunology); Spinal Cord(immunology; pathology); T-Lymphocytes(immunology; metabolism); Th1 Cells(immunology; metabolism); Theilovirus(genetics; immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>174</Volume>
                <Issue>2</Issue>
                <Title>Journal of immunology (Baltimore, Md. : 1950)</Title>
                <Issn>0022-1767</Issn>
                <MedlineTa>J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>HI&lt;sub&gt;574-586&lt;/sub&gt;</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>EQLVKWLGLPAPI</LinearSequence>
                        <StartingPosition>573</StartingPosition>
                        <EndingPosition>585</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P45243.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>727</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>13882</EpitopeId>
                <ReferenceStartingPosition>574</ReferenceStartingPosition>
                <ReferenceEndingPosition>586</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Mimic HI 574-586 epitope from Haemophilus influenzae shares 6/13 residues with PLP 139-151 from encephalitogenic proteolipid protein (PLP) in mouse.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 5-6</LocationOfData>
                        <TCellId>1377686</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000649</OrganismId>
                                <Sex>F</Sex>
                                <Age>5-6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EQLVKWLGLPAPI</LinearSequence>
                                            <StartingPosition>573</StartingPosition>
                                            <EndingPosition>585</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P45243.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>727</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HI&lt;sub&gt;574-586&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <ImmunogenContainingObject>
                                    <RecombinantOrganism>
                                        <SubType>Recombinant Organism</SubType>
                                    </RecombinantOrganism>
                                </ImmunogenContainingObject>
                                <Route>Intracarotid (i.c.)</Route>
                                <DoseSchedule>One dose of 3 x 10&lt;sup&gt;7&lt;/sup&gt; PFU of TMEV encoding epitope i.c.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice infected with TMEV encoding the epitope developed early and mild EAE, but not the mice immunized with the epitope peptide. .</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>137</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PLP&lt;sub&gt;139-151&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Other</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HCLGKWLGHPDKF</LinearSequence>
                                        <StartingPosition>140</StartingPosition>
                                        <EndingPosition>152</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60202.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>However T cells from mice immunized with the epitope alone did not respond to PLP&lt;sub&gt;139-151&lt;/sub&gt; for IFN-%gamma; release.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 3 and 5-6</LocationOfData>
                        <TCellId>2052</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000649</OrganismId>
                                <Sex>F</Sex>
                                <Age>5-6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EQLVKWLGLPAPI</LinearSequence>
                                            <StartingPosition>573</StartingPosition>
                                            <EndingPosition>585</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P45243.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>727</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HI&lt;sub&gt;574-586&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>One dose of 100 µg of peptide in CFA s.c. over 3 sites on lateral hind flanks and dorsally.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice infected with TMEV encoding the epitope developed early and mild EAE, but not the mice immunized with the epitope peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>137</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HI&lt;sub&gt;574-586&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EQLVKWLGLPAPI</LinearSequence>
                                        <StartingPosition>573</StartingPosition>
                                        <EndingPosition>585</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P45243.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>727</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>T cells from mice immunized with the epitope cross reacted with PLP&lt;sub&gt;139-151&lt;/sub&gt;. Similar results were observed when mice were infected with TMEV virus containing the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 3 and 5-6</LocationOfData>
                        <TCellId>1377684</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000649</OrganismId>
                                <Sex>F</Sex>
                                <Age>5-6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EQLVKWLGLPAPI</LinearSequence>
                                            <StartingPosition>573</StartingPosition>
                                            <EndingPosition>585</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P45243.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>727</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HI&lt;sub&gt;574-586&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>One dose of 100 µg of peptide in CFA s.c. over 3 sites on lateral hind flanks and dorsally.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice infected with TMEV encoding the epitope developed early and mild EAE, but not the mice immunized with the epitope peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>137</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PLP&lt;sub&gt;139-151&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Other</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HCLGKWLGHPDKF</LinearSequence>
                                        <StartingPosition>140</StartingPosition>
                                        <EndingPosition>152</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60202.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>T cells from mice immunized with the epitope cross reacted with PLP&lt;sub&gt;139-151&lt;/sub&gt;. Similar results were observed when mice were infected with TMEV virus containing the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 3 and 5-6</LocationOfData>
                        <TCellId>1377685</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000649</OrganismId>
                                <Sex>F</Sex>
                                <Age>5-6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>EQLVKWLGLPAPI</LinearSequence>
                                            <StartingPosition>573</StartingPosition>
                                            <EndingPosition>585</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P45243.1</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>727</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>HI&lt;sub&gt;574-586&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>One dose of 100 µg of peptide in CFA s.c. over 3 sites on lateral hind flanks and dorsally.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Mice infected with TMEV encoding the epitope developed early and mild EAE, but not the mice immunized with the epitope peptide.</ImmunizationComments>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>137</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HI&lt;sub&gt;574-586&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EQLVKWLGLPAPI</LinearSequence>
                                        <StartingPosition>573</StartingPosition>
                                        <EndingPosition>585</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P45243.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>727</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Similar results were observed when mice were infected with TMEV virus containing the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>PLP&lt;sub&gt;139-151&lt;/sub&gt;</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>HCLGKWLGHPDKF</LinearSequence>
                        <StartingPosition>140</StartingPosition>
                        <EndingPosition>152</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P60202.2</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>10090</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>23599</EpitopeId>
                <ReferenceStartingPosition>139</ReferenceStartingPosition>
                <ReferenceEndingPosition>151</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Mimic HI 574-586 epitope from Haemophilus influenzae shares 6/13 residues with PLP 139-151 from encephalitogenic proteolipid protein (PLP) in mouse.</EpitopeComments>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 3 and 5-6</LocationOfData>
                        <TCellId>1377692</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000649</OrganismId>
                                <Sex>F</Sex>
                                <Age>5-6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HCLGKWLGHPDKF</LinearSequence>
                                            <StartingPosition>140</StartingPosition>
                                            <EndingPosition>152</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60202.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PLP&lt;sub&gt;139-151&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>One dose of 100 µg of peptide in CFA s.c. over 3 sites on lateral hind flanks and dorsally.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>137</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PLP&lt;sub&gt;139-151&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HCLGKWLGHPDKF</LinearSequence>
                                        <StartingPosition>140</StartingPosition>
                                        <EndingPosition>152</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60202.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>T cells from mice immunized with the epitope cross reacted with HI&lt;sub&gt;574-586&lt;/sub&gt;. Similar results were observed when mice were infected with TMEV virus containing the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 5-6</LocationOfData>
                        <TCellId>1377693</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000649</OrganismId>
                                <Sex>F</Sex>
                                <Age>5-6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HCLGKWLGHPDKF</LinearSequence>
                                            <StartingPosition>140</StartingPosition>
                                            <EndingPosition>152</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60202.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PLP&lt;sub&gt;139-151&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>One dose of 100 µg of peptide in CFA s.c. over 3 sites on lateral hind flanks and dorsally.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>137</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HI&lt;sub&gt;574-586&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Other</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EQLVKWLGLPAPI</LinearSequence>
                                        <StartingPosition>573</StartingPosition>
                                        <EndingPosition>585</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P45243.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>727</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>73</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>T cells from mice immunized with the epitope cross reacted with HI&lt;sub&gt;574-586&lt;/sub&gt;. Similar results were observed when mice were infected with TMEV virus containing the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 3 and 5-6</LocationOfData>
                        <TCellId>1377688</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000649</OrganismId>
                                <Sex>F</Sex>
                                <Age>5-6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HCLGKWLGHPDKF</LinearSequence>
                                            <StartingPosition>140</StartingPosition>
                                            <EndingPosition>152</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60202.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PLP&lt;sub&gt;139-151&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>One dose of 100 µg of peptide in CFA s.c. over 3 sites on lateral hind flanks and dorsally.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>137</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>PLP&lt;sub&gt;139-151&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>HCLGKWLGHPDKF</LinearSequence>
                                        <StartingPosition>140</StartingPosition>
                                        <EndingPosition>152</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P60202.2</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>T cells from mice immunized with the epitope cross reacted with HI&lt;sub&gt;574-586&lt;/sub&gt;. Similar results were observed when mice were infected with TMEV virus containing the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
                <Assays>
                    <TCell>
                        <LocationOfData>Figures 3 and 5-6</LocationOfData>
                        <TCellId>1377691</TCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000649</OrganismId>
                                <Sex>F</Sex>
                                <Age>5-6 weeks old</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>HCLGKWLGHPDKF</LinearSequence>
                                            <StartingPosition>140</StartingPosition>
                                            <EndingPosition>152</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P60202.2</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>10090</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>PLP&lt;sub&gt;139-151&lt;/sub&gt;</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>One dose of 100 µg of peptide in CFA s.c. over 3 sites on lateral hind flanks and dorsally.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <EffectorCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>T cell CD4+</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </EffectorCells>
                        <AntigenPresentingCells>
                            <CellTissueType>Spleen</CellTissueType>
                            <CellType>Splenocyte</CellType>
                            <CellCultureConditions>Direct Ex Vivo</CellCultureConditions>
                        </AntigenPresentingCells>
                        <MhcAllele>
                            <MhcAlleleId>137</MhcAlleleId>
                            <MhcEvidenceCode>T cell assay -T cell subset identification</MhcEvidenceCode>
                        </MhcAllele>
                        <Antigen>
                            <AntigenReferenceName>HI&lt;sub&gt;574-586&lt;/sub&gt;</AntigenReferenceName>
                            <AntigenObject>
                                <EpitopeRelation>Other</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>EQLVKWLGLPAPI</LinearSequence>
                                        <StartingPosition>573</StartingPosition>
                                        <EndingPosition>585</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P45243.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>727</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <AssayInformation>
                            <AssayTypeId>69</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>T cells from mice immunized with the epitope cross reacted with HI&lt;sub&gt;574-586&lt;/sub&gt;. Similar results were observed when mice were infected with TMEV virus containing the epitope.</AssayComments>
                        </AssayInformation>
                    </TCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

